BioMS Medical named Biotech Company of the Year
Company to receive Gold Leaf Award from BIOTECanada at BIO 2008
"This award recognizes the Canadian biotech company that has distinguished itself from its peers with strong overall performance as a company, demonstrated leadership and significant achievement," said Peter Brenders, President and CEO of BIOTECanada. "BioMS Medical represents these qualities and is recognized as a leader in Canadian biotech."
"We are honored to have received this prestigious award from BIOTECanada," said Kevin Giese, President and CEO of BioMS Medical. "In 2007 we achieved many significant milestones as we advanced our lead drug for MS, MBP8298 (dirucotide). This award recognizes the significant efforts made by the dedicated employees at BioMS and the great progress we've made."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.